In the early stages of BC, the highest area under the ROC curve (AUC) of all tested parameters was observed for CCL2 or CCR2 (stage I: 0.6604 and 0.6564, respectively; stage II: 0.7768 for CCR2). This evidence concerns the gene CCR2 and breast cancer.